Mallaro and Stolz to Get New Roles at VGM

Published in Member Communities on October 16, 2023

Jeremy Stolz and Mike Mallar

VGM Group has announced that CEO Mike Mallaro will transition to a new role as executive chairman of the company’s board of directors on Jan. 1, 2024. 

Jeremy Stolz, who is currently president of VGM Fulfillment and VGM & Associates, will take over as CEO of VGM Group. 

The changes are part of a multi-year transition plan, the company says. 

“VGM has always been focused on our members, our vendor partners, our industry and our employee-owners,” said Mallaro, who joined VGM in 2001 as CFO and has served as its CEO for the past eight years. “A thoughtful and strategic leadership transition process is an important investment in our future. During our thorough succession and search process, Jeremy emerged as the ideal candidate to lead our company forward.” 

Stolz, who has been with VGM for more than 20 years, will be the third CEO in the company’s history, following Mallaro and Van G. Miller. 

Stolz launched VGM Fulfillment in 2009, becoming president of the division in 2017. Under his leadership, VGM Fulfillment grew to become one of VGM’s largest divisions and a key player in the CPAP resupply business. Stolz has also been president of VGM & Associates since the summer of 2022. 

“I am honored to be able to serve VGM Group and the HME industry,” Stolz said. “Change, especially in our industry, is constant. One thing I can assure you will never change is VGM’s commitment to supporting the HME industry that provides invaluable care to our most vulnerable population. I, along with our more than 1,500 employee owners across VGM, are here to serve you.” 

VGM Group will soon begin the search for a new president for VGM Fulfillment and VGM & Associates. The company says that the ideal candidates will be proven leaders within the HME industry and that it will consider both internal and external applicants. 


TAGS

  1. vgm

From Our Experts

What the Numotion/Hanger Merger Could Mean for CRT and O&P Providers thumbnail What the Numotion/Hanger Merger Could Mean for CRT and O&P Providers Read what the proposed Numotion/Hanger merger could mean for CRT and O&P providers from VGM's SVP of Membership, Tyler Mahncke. What the Numotion/Hanger Merger Could Mean for CRT and O&P Providers thumbnail What the Numotion/Hanger Merger Could Mean for CRT and O&P Providers Read what the proposed Numotion/Hanger merger could mean for CRT and O&P providers from VGM's SVP of Membership, Tyler Mahncke. Turning Unmet OSA Need Into Measurable Referral Growth thumbnail Turning Unmet OSA Need Into Measurable Referral Growth Discover strategies for HME providers to convert undiagnosed OSA into referral growth by enhancing PCP relationships and improving patient care outcomes. Turning Unmet OSA Need Into Measurable Referral Growth thumbnail Turning Unmet OSA Need Into Measurable Referral Growth Discover strategies for HME providers to convert undiagnosed OSA into referral growth by enhancing PCP relationships and improving patient care outcomes. Before You Add a New Product Line, Ask These Seven Questions thumbnail Before You Add a New Product Line, Ask These Seven Questions Explore the key reimbursement, accreditation, compliance, and operational considerations DMEPOS providers should evaluate before expanding services. A Pattern We're Seeing Across Healthcare thumbnail A Pattern We're Seeing Across Healthcare Insights on how healthcare providers can build trust, clarity, & confidence for patients, referral sources, & employees while navigating industry complexity. Medicare DMEPOS Compliance Updates: New F2F, WOPD, & Prior Authorization Requirements thumbnail Medicare DMEPOS Compliance Updates: New F2F, WOPD, & Prior Authorization Requirements Medicare is expanding DMEPOS compliance requirements, with new Face-to-Face (F2F), Written Order Prior to Delivery (WOPD), and Prior Authorization rules taking effect in 2026 and 2027. What AI and Industry Leaders Predict for HME's Future thumbnail What AI and Industry Leaders Predict for HME's Future Discover why HME growth remains strong despite reimbursement uncertainty, increased audits, staffing challenges, and operational pressures.